PEG.CO
Price:
$0.103
Market Cap:
$126.44M
Pharma Equity Group A/S invests in companies with a primary focus on life sciences. It focuses on early investment in life science companies that develop technologies and therapies that enhances human health and quality of life. The company is based in Hørsholm, Denmark.
Industry
Biotechnology
IPO Date
2023-05-16
Stock Exchange
CPH
Ticker
PEG.CO
According to Pharma Equity Group A/S’s latest financial reports and current stock price. The company's current PE Ratio is -5.15. This represents a change of -36.39% compared to the average of -8.10 of the last 4 quarters.
The mean historical PE Ratio of Pharma Equity Group A/S over the last ten years is 1.48. The current -5.15 PE Ratio has changed -34792.08% with respect to the historical average. Over the past ten years (40 quarters), PEG.CO's PE Ratio was at its highest in in the December 2022 quarter at 9.40. The PE Ratio was at its lowest in in the September 2022 quarter at -41.59.
Average
1.48
Median
-2.24
Minimum
-18.88
Maximum
51.49
Discovering the peaks and valleys of Pharma Equity Group A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.25%
Maximum Annual PE Ratio = 51.49
Minimum Annual Increase = -1164.88%
Minimum Annual PE Ratio = -18.88
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -8.31 | -55.97% |
| 2023 | -18.88 | -529.50% |
| 2022 | 4.40 | 4.01% |
| 2021 | 4.23 | -1164.88% |
| 2020 | -0.40 | -93.15% |
| 2019 | -5.80 | 357.75% |
| 2018 | -1.27 | -102.46% |
| 2017 | 51.49 | -795.51% |
| 2016 | -7.40 | 130.33% |
| 2015 | -3.21 | 2.25% |
The current PE Ratio of Pharma Equity Group A/S (PEG.CO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.60
5-year avg
-3.79
10-year avg
1.48
Pharma Equity Group A/S’s PE Ratio is less than Scandinavian Medical Solutions A/S (37.38), greater than ViroGates A/S (-9.42), less than Stenocare A/S (-2.14), less than Monsenso A/S (-1.93), less than Brain+ A/S (-0.35),
| Company | PE Ratio | Market cap |
|---|---|---|
| 37.38 | $105.49M | |
| -9.42 | $119.51M | |
| -2.14 | $62.19M | |
| -1.93 | $12.75M | |
| -0.35 | $11.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharma Equity Group A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharma Equity Group A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pharma Equity Group A/S's PE Ratio?
How is the PE Ratio calculated for Pharma Equity Group A/S (PEG.CO)?
What is the highest PE Ratio for Pharma Equity Group A/S (PEG.CO)?
What is the 3-year average PE Ratio for Pharma Equity Group A/S (PEG.CO)?
What is the 5-year average PE Ratio for Pharma Equity Group A/S (PEG.CO)?
How does the current PE Ratio for Pharma Equity Group A/S (PEG.CO) compare to its historical average?